Pharmacokinetics and radiation dosimetry of 18F-fluorocholine.
Timothy R DeGrado, Robert E Reiman, David T Price...
https://pubmed.ncbi.nlm.nih.gov/11801711/Actively Recruiting
Led by Andrei Iagaru · Updated on 2026-06-24
100
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are evaluating the use of a PET isotope called Fluorine-18 18F attached to Choline in people suspected of having parathyroid adenoma who have negative or unclear results from the standard 99mTc Sestamibi SPECTCT scan. The study focuses on detecting parathyroid adenomas using this new imaging technique in a single-center, single-arm trial. Participants receive an intravenous injection of 18F Fluorocholine about 5 mCi with a 20% margin, followed 45 to 60 minutes later by a low dose CT scan from the skull base to mid-thighs. This is immediately followed by a static PET emission scan over the same area, aiming to locate parathyroid adenomas more effectively than the standard scan. During the study, participants undergo the PETCT imaging process once, and researchers measure the number of lesions detected within an hour after the scan. Safety is monitored through blood tests and heart monitoring prior to the scan. The total participation time is brief and focused on imaging and related assessments.
CONDITIONS
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
A
Andrea Otte, DPT
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Andrei Iagaru
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | 18F Fluorocholine PET/CT | 99mTc Sestamibi SPECT/CT (Current Conventional Imaging) |
|---|---|---|
| What it is | A diagnostic imaging technique using intravenous 18F Fluorocholine combined with PET/CT to identify parathyroid adenomas. | A conventional nuclear medicine scan using 99mTc Sestamibi and SPECT/CT to detect parathyroid adenomas. |
| Role in trial | All participants receive this PET/CT scan to localize suspected parathyroid adenoma after inconclusive Sestamibi imaging. | Current initial imaging used to localize parathyroid adenoma before considering further studies. |
| Primary use | Evaluation of parathyroid adenoma localization when conventional Sestamibi imaging does not provide a clear result. | First-line imaging for patients with suspected parathyroid adenoma. |
| How it is given or performed | A small amount of 18F Fluorocholine is injected into a vein, and PET/CT images are taken to detect abnormal parathyroid tissue. | 99mTc Sestamibi is administered intravenously, followed by SPECT/CT imaging to localize abnormal parathyroid tissue. |
| Evidence status | Growing clinical evidence supports high sensitivity for localizing parathyroid adenomas, especially when conventional imaging is inconclusive. | Widely used with established diagnostic performance, but sensitivity decreases in some patients leading to equivocal or negative scans. |
| Important limitations | Limited availability, cost, and investigational status for this indication; long-term results and access across centers may vary. | Reduced sensitivity in some patients and can result in negative or equivocal results, particularly in multi-gland disease or small lesions. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single visit lasting approximately 1 to 2 hours
Participants receive an intravenous injection of 18F Fluorocholine followed by a low-dose CT scan and a PET emission scan from the skull base to mid-thighs to detect parathyroid adenomas.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Timothy R DeGrado, Robert E Reiman, David T Price...
https://pubmed.ncbi.nlm.nih.gov/11801711/Wouter P Kluijfhout, Jesse D Pasternak, Jessica E Gosnell...
https://pubmed.ncbi.nlm.nih.gov/28121522/Thomas A Hope, Claire E Graves, Jeremie Calais...
https://pubmed.ncbi.nlm.nih.gov/33674400/Renaud Ciappuccini, Julia Morera, Pierre Pascal...
https://pubmed.ncbi.nlm.nih.gov/22310246/Claire E Graves, Thomas A Hope, Jina Kim...
https://pubmed.ncbi.nlm.nih.gov/34301418/Andrei Iagaru
Lead Sponsor